44 results on '"Psychedelic"'
Search Results
2. Discriminative stimulus properties of α-ethyltryptamine (α-ET) in rats: α-ET-like effects of MDMA, MDA and aryl-monomethoxy substituted derivatives of α-ET
3. Ketamine-induced altered states of consciousness: a systematic review of implications for therapeutic outcomes in psychiatric practices
4. Knowledge, attitudes, and concerns about psilocybin and MDMA as novel therapies among U.S. healthcare professionals
5. Neuroprotective effects of psilocybin in a rat model of stroke
6. Cognitive functioning associated with acute and subacute effects of classic psychedelics and MDMA - a systematic review and meta-analysis
7. Psychedelic-assisted psychotherapy: where is the psychotherapy research?
8. Minorities’ Diminished Psychedelic Returns: Income and Educations Impact on Whites, Blacks, Hispanics, and Asians
9. The Use of Illicit Drugs in Therapy: an Introduction
10. The Structural Organization and Construct Validity Evidence of the Brazilian Versions of the Mysticism Scale and the Ego-Dissolution Inventory in a Major Religion of the Ayahuasca
11. Psychedelic Therapy as Form of Life
12. When the Trial Ends: The Case for Post-Trial Provisions in Clinical Psychedelic Research
13. The Potential for Psychedelics to Improve Coping Skills and Resilience in Persons With Newly Diagnosed Mild Cognitive Impairment or Early Alzheimer’s Disease
14. Reconsidering “dissociation” as a predictor of antidepressant efficacy for esketamine
15. Systematic Review: Is There a Medicinal Use of Cocaine in Psychiatry?
16. Use of the head-twitch response to investigate the structure–activity relationships of 4-thio-substituted 2,5-dimethoxyphenylalkylamines
17. Psilocybin Efficacy and Mechanisms of Action in Major Depressive Disorder: a Review
18. The use patterns of novel psychedelics: experiential fingerprints of substituted phenethylamines, tryptamines and lysergamides
19. Low doses of LSD reduce broadband oscillatory power and modulate event-related potentials in healthy adults
20. Serotonin toxicity of serotonergic psychedelics
21. Modulatory effects of ayahuasca on personality structure in a traditional framework
22. In vitro structure–activity relationship determination of 30 psychedelic new psychoactive substances by means of β-arrestin 2 recruitment to the serotonin 2A receptor
23. Compassionate use of psychedelics
24. Subjective features of the psilocybin experience that may account for its self-administration by humans: a double-blind comparison of psilocybin and dextromethorphan
25. Designer drugs: mechanism of action and adverse effects
26. Effects of the synthetic psychedelic 2,5-dimethoxy-4-iodoamphetamine (DOI) on ethanol consumption and place conditioning in male mice
27. Replication and extension of a model predicting response to psilocybin
28. RETRACTED ARTICLE: MDMA-assisted psychotherapy for treatment of PTSD: study design and rationale for phase 3 trials based on pooled analysis of six phase 2 randomized controlled trials
29. A single inhalation of vapor from dried toad secretion containing 5-methoxy-N,N-dimethyltryptamine (5-MeO-DMT) in a naturalistic setting is related to sustained enhancement of satisfaction with life, mindfulness-related capacities, and a decrement of psychopathological symptoms
30. 25C-NBOMe, a Novel Designer Psychedelic, Induces Neurotoxicity 50 Times More Potent Than Methamphetamine In Vitro
31. Microdosing psychedelics: personality, mental health, and creativity differences in microdosers
32. Psychedelic microdosing benefits and challenges: an empirical codebook
33. Double-blind comparison of the two hallucinogens psilocybin and dextromethorphan: similarities and differences in subjective experiences
34. Psilocybin with psychological support for treatment-resistant depression: six-month follow-up
35. Zeichnen unter Einfluss von Halluzinogenen
36. Potential Therapeutic Effects of Psilocybin
37. LSD enhances the emotional response to music
38. Interaction of psychoactive tryptamines with biogenic amine transporters and serotonin receptor subtypes
39. Dose-related effects of salvinorin A in humans: dissociative, hallucinogenic, and memory effects
40. High doses of dextromethorphan, an NMDA antagonist, produce effects similar to classic hallucinogens
41. Acute and post-acute behavioral and psychological effects of salvinorin A in humans
42. Psilocybin occasioned mystical-type experiences: immediate and persisting dose-related effects
43. Dimethyltryptamine and other hallucinogenic tryptamines exhibit substrate behavior at the serotonin uptake transporter and the vesicle monoamine transporter
44. Platelet serotonin uptake sites increased in drinkers ofayahuasca
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.